T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variantsDaniel Hirschhorn, Taha Merghoub|Cell|2023Cited by 290
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Charles M. Rudin, Barzin Y. Nabet et al.|Immunity|2022Cited by 123